The Game-Changing Trend Reshaping Artificial Intelligence in Healthcare Diagnosis Market Size and Growth in 2025

 The Business Research Company’s report on the Artificial Intelligence in Healthcare Diagnosis Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.


 
 Which emerging drivers are set to accelerate the growth of the artificial intelligence in healthcare diagnosis market further?
 The rising incidence rate of chronic diseases is expected to propel the growth of artificial intelligence in the healthcare diagnosis market going forward. Chronic diseases are long-term health conditions that generally progress slowly over time and often persist intermittently. Artificial Intelligence (AI) in healthcare diagnosis has the potential to significantly impact the management and diagnosis of chronic diseases as it can aid in cost savings and improved resource use. It can help medical practitioners make better decisions, spot patients in danger, and give more individualized care. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising incidence rate of chronic diseases is driving the growth of artificial intelligence in the healthcare diagnosis market.
 
 Access Your Free Sample of the Global Artificial Intelligence in Healthcare Diagnosis Market Report — Get Insights Now!
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12609&type=smp
 
 What are the key factors influencing the forecasted market size of the artificial intelligence in healthcare diagnosis industry?
 The artificial intelligence in healthcare diagnosis market size has grown exponentially in recent years. It will grow from $23.18 billion in 2024 to $33.24 billion in 2025 at a compound annual growth rate (CAGR) of 43.4%. The growth in the historic period can be attributed to advancements in medical imaging, data accessibility and digitization, clinical workflow optimization, research and development investments, shortage of healthcare professionals
 
 The artificial intelligence in healthcare diagnosis market size is expected to see exponential growth in the next few years. It will grow to $155.31 billion in 2029 at a compound annual growth rate (CAGR) of 47.0%. The growth in the forecast period can be attributed to ai-powered precision medicine, integration with electronic health records, expansion of medical imaging analysis, rise of wearable health tech, regulatory support and standards. Major trends in the forecast period include explainable ai in healthcare, ai-driven early disease detection, telehealth integration, ai in pathology and histopathology, ai-enabled point-of-care diagnostics.
 
 Gain Exclusive Market Insights — Customize Your Research Report Today For Fast Delivery!
 https://www.thebusinessresearchcompany.com/customise?id=12609&type=smp
 
 Who are the leading competitors in the artificial intelligence in healthcare diagnosis market?
 Major companies operating in the artificial intelligence in healthcare diagnosis market include Johnson and Johnson Private Limited, Intel Corporation, International Business Machines Corporation, Medtronic, Nvidia Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare, Agfa-Gevaert Group, Google Deep Mind, Babylon Health, HeartFlow Inc., Corti HQ, Aidoc, Aidoc Medical Ltd., Imagen Technologies, AliveCor Inc., Digital Diagnostics Inc., Enlitic Inc., NovaSignal Corp., Cleerly Inc., Butterfly Network Inc., IBM Watson Health, Arterys Inc., Zebra Medical Vision Inc., Vuno Inc., Riverain Technologies, CloudMedX Inc., Neural Analytics Inc.
 
 Which emerging trends are set to transform the artificial intelligence in healthcare diagnosis market landscape?
 Technological advancement is a key trend gaining popularity in artificial intelligence in the healthcare diagnosis market. Major companies operating in artificial intelligence in the healthcare diagnosis market are concentrating on creating innovative technologies to sustain their position in the market. For instance, in March 2023, Genomic Vision, a France-based biotechnology company, launched FiberSmart, an AI-powered software to automate detecting and quantifying fluorescent signals on combed DNA (Deoxyribonucleic acid) molecules. FiberSmart offers a simple and user-friendly interface, allowing fast analysis of DNA replication signals to deduce essential parameters describing replication kinetics. Compared to Genomic Vision’s current software solutions, the program uses advanced AI techniques to visualize, detect, and evaluate DNA replication kinetics up to three times more accurately and up to ten times faster. FiberSmart’s user-friendly interface and ergonomic design enable quick analysis of DNA replication signals to determine crucial variables describing replication kinetics.
 
 How do different geographies compare in terms of market share and growth potential in the artificial intelligence in healthcare diagnosis market?
 North America was the largest region in the artificial intelligence in healthcare diagnosis market in 2024. The regions covered in the artificial intelligence in healthcare diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
 
 Order Your Report Now For Swift Delivery
 https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-diagnosis-global-market-report
 
 Which major segments of the artificial intelligence in healthcare diagnosis market are experiencing the fastest growth?
 The artificial intelligence in healthcare diagnosis market covered in this report is segmented –
 
 1) By Component: Software, Services, Hardware
 2) By Diagnosis: Cardiology, Oncology, Pathology, Radiology, Chest And Lung, Neurology, Other Diagnoses
 3) By Modality: MRI (Magnetic Resonance Imaging), CT (Computed Tomography), X-ray, Ultrasound
 4) By Application: In Vivo Diagnostics, In Vitro Diagnostics
 5) By End-User: Hospitals, Diagnostics Imaging Centers, Diagnostics Laboratories, Other End-Users
 
 Subsegments:
 1) By Software: Diagnostic Software, Imaging Analysis Software, Predictive Analytics Software
 2) By Services: Consulting Services, Implementation Services, Maintenance And Support Services
 3) By Hardware: Diagnostic Imaging Devices, AI-Powered Medical Devices, Data Storage And Processing Hardware
 
 Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12609
 
 How is the artificial intelligence in healthcare diagnosis market defined, and what are its core characteristics?
 Artificial intelligence (AI) in healthcare diagnosis refers to applying AI techniques, such as machine learning and deep learning algorithms, to diagnose medical conditions. It is employed to evaluate data, including clinical trials, medical records, and genetic information, that can aid medical practitioners in making a diagnosis much more quickly than any human could.
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. 
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments